12

Nov

2020

15:00

GMT

Webinar

Technological Iteration in TAVI: A Live Case Session

Average (ratings)
No ratings
Your rating

Overview

Join us for a live discussion and live case performance on:

  • Benefits of latest technology iterations in TAVI to increase safety and efficacy
  • ACURATE neo2™ in clinical practice: Live case from St. Johannes Hospital, Dortmund
  • Design, results, and limitations of TAVI trials involving the ACURATE neo Valve Platform
  • How the heart team should individualize the treatment of TAVI patients

Faculty:


Helge Möllmann

Helge Möllmann


Lars Søndergaard

Lars Søndergaard


Pablo Lamelas

Pablo Lamelas


Won Keun-Kim

Won Keun-Kim

This webinar is supported by

Agenda

15:00 – 15:03

Introduction & objectives

15:03 – 15:08

Live case introduction from St Johannes Hospital, Germany -Prof Helge Möllmann (Germany)

15:08 – 15:18

Critical appraisal of the ACURATE neo/neo2 clinical program -Prof Lars Søndergaard (Denmark)

15:18 - 15:23

Panel discussion-All faculty members

15:23 – 16:08

TAVI Live case from St Johannes Hospital, Germany -Prof Helge Möllmann (Germany)

16:08 - 16:28

Panel discussion -All faculty members

16:28 – 16:30

Closing remarks

Faculty Biographies


Helge Möllmann

Helge Möllmann

Prof Helge Möllmann is a distinguished cardiologist and the Director of the Clinic for Internal Medicine (Cardiology) at St Johannes Hospital in Dortmund, Germany. With a prolific career in cardiovascular medicine, he has authored over 520 publications, contributing significantly to the advancement of cardiology research and clinical practice.

Prof Helge Möllmann is an esteemed member of several prominent cardiology organisations, including the German Society for Cardiology (DGK) and the Interventional Cardiology Working Group of the DGK. Prof Helge Möllmann's expertise and leadership are further recognised through his roles as a Nucleus member of the European Society of Cardiology (ESC), as well as his involvement in the German Mitral Valve Steering Committee and the German Aortic Valve Executive Board.

View full profile

Lars Søndergaard

Lars Søndergaard

Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions, as well as congenital and structural heart diseases. He led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012 and he actively participated to several trials, including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).

View full profile

Pablo Lamelas

Pablo Lamelas

Interventional Cardiologist, Instituto Cardiovascular de Buenos Aires (ICBA)
His areas of interest have centered around Coronary, complex angioplasty, chronic total occlusion angioplasty and structural heart disease interventions.

View full profile

Won Keun-Kim

Won Keun-Kim

Interventional Cardiologist Kerckhoff Heart Center, Bad Nauheim, Germany
Dr Won-Keun Kim is Director of Structural Heart Disease / TAVI at the Kerckhoff Heart Center, Bad Nauheim, Germany. Between 2012-2016 Dr Kim served as Interdisciplinary Consultant, Cardiology / Cardiac Surgery, and Associate Director of the Interventional Cardiology Training Program also at the Kerckhoff Heart Center, where he previously worked as a specialist in cardiology, interventional cardiology and cardiovascular imaging.

View full profile